[1] FLORIANI C, GENCER B, COLLET T H, et al. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update[J]. Eur Heart J, 2017, 39(7): 503-507. [2] PEARCE E N. Update in lipid alterations in subclinical hypothyroidism[J]. J Clin Endocrinol Metab, 2012, 97(2): 326-333. [3] FU G, SUN X, YAN Y, et al. The changes in coagulation test results in subjects with varying levels of thyroid stimulating hormone[J]. Clin Lab, 2019, 65(9): 1655-1660. [4] VANDERMOLEN S, ABBOTT J, DE SILVA K. What’s age got to do with it? A review of contemporary revascularization in the elderly[J]. Curr Cardiol Rev, 2015, 11(3): 199-208. [5] SAHIN E, BEKTUR E, BAYCU C, et al. Hypothyroidism increases expression of sterile inflammation proteins in rat heart tissue[J]. Acta Endocrinol: Buchar, 2019, 5(1): 39-45. [6] YAU J W, TEOH H, VERMA S. Endothelial cell control of thrombosis[J]. BMC Cardiovasc Disord, 2015, 15: 130. [7] YE Y, XIE H, ZENG Y, et al. Association between subclinical hypothyroidism and blood pressure-a meta-analysis of observational studies[J]. Endocr Pract, 2014, 20(2): 150-158. [8] BIONDI B, COOPER D S. The clinical significance of subclinical thyroid dysfunction[J]. Endocr Rev, 2008, 29(1): 76-131. [9] MARFELLA R, FERRARACCIO F, RIZZO M R, et al. Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism[J]. J Clin Endocrinol Metab, 2011, 96(4): 1015-1020. [10] GUSSEKLOO J, VAN EXEL E, DE CRAEN A J, et al. Thyroid status, disability and cognitive function, and survival in old age[J]. JAMA, 2004, 29(21): 2591-2599. [11] HYLAND K A, ARNOLD A M, LEE J S, et al. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study[J]. J Clin Endocrinol Metab, 2013, 98(2): 533-540. [12] GROSSMAN A, WEISS A, KOREN-MORAG N, et al. Subclinical thyroid disease and mortality in the elderly: a retrospective cohort study[J]. Am J Med, 2016, 129(4): 423-430. |